Trial Profile
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dalcetrapib (Primary) ; Atorvastatin
- Indications Coronary disorders
- Focus Therapeutic Use
- Sponsors Roche